Our differentiated, physics-based software platform enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly, at lower cost, and with, we believe, a higher likelihood of success compared to traditional methods.
$14.00 - $16.00
February 6, 2020
MORGAN STANLEY & CO. LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Schrodinger, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277